Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study was aimed to evaluate efficacy and tolerability of thalidomide in improving
prevention of chemotherapy-induced delayed nausea and vomiting in chemotherapy-naive patients
after highly emetogenic chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
China Medical University, China
Collaborators:
Anshan Tumor Hospital General Hospital of Shenyang Military Region Liaoning Tumor Hospital & Institute Liaoyang Central Hospital Petrochemical General Hospital of Liaoyang city Shengjing Hospital The First Affiliated Hospital of Dalian Medical University The First Hospital of Liaoning Medical University The Second Affiliated Hospital of Dalian Medical University Third People's hospital Liaoyang